| 产品描述: | PT-262 是一种有效的 ROCK 抑制剂,IC50 值约为 5 μM。PT-262 诱导线粒体膜电位的丧失并提高 caspase-3 的激活和细胞凋亡。PT-262 通过 p53 独立途径抑制 ERK 和 CDC2 磷酸化。PT-262 阻断细胞骨架功能和细胞迁移。PT-262 具有抗癌活性。 |
| 靶点: |
ROCK:5 μM (IC50); ERK;CDK2 |
| 体内研究: |
PT-262 (5-40 μM; 24 h) induces cytotoxicity and proliferation inhibition in human lung cancer cells[1]. PT-262 (2-20 μM; 4-24 h) induces caspase-3 activation, mitochondrial dysfunction and apoptosis in lung cancer cells[1]. PT-262 (10-20 μM; 24 h) induces the accumulation of G2/M phases in both the p53-wild type and p53-null lung cancer cells, and inhibits the phosphorylation of CDC2 proteins[1]. PT-262 (0-10 μM; 24 h) represses ERK phosphorylation in lung cancer cells[1]. PT-262 (2 μM; 24 h) induces the cytoskeleton alteration and cell elongation in lung carcinoma A549 cells[2]. PT-262 (2-10 μM; 6 h) significantly blocks the cell migration in a concentration-dependent manner[2]. |
| 保存条件: |
-80°C 12个月; -20°C 6个月,干燥, 避光 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.614 ml |
18.069 ml |
36.138 ml |
| 5 mM |
0.723 ml |
3.614 ml |
7.228 ml |
| 10 mM |
0.361 ml |
1.807 ml |
3.614 ml |
| 50 mM |
0.072 ml |
0.361 ml |
0.723 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |